Heerspink HJL, van Raalte DH, Bjornstad P et al. · Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · PMID 41160422
From the original abstract
“TRANSCEND-CKD is designed to provide mechanistic insights on the effects of retatrutide on kidney function and structure, and to inform clinical findings in the ongoing…”
From the abstract’s conclusions section. This is a shortened quotation; the full sentence continues in the original abstract.
Read the full abstract & conclusionRead the full methods for the participants, comparison group, outcomes, and follow-up. A trial publication may report a secondary analysis of an existing trial rather than new participants.
A brief excerpt cannot capture the complete methods, results, adverse events, or limitations. Check the full abstract and original paper before interpreting the finding.
Educational research information. A publication does not verify the identity, quality, or safety of products sold here.
Back to Retatrutide studies